This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2009 Sep;33(9):e164-5.

doi: 10.1016/j.leukres.2009.03.024. Epub 2009 Apr 16.

CD8+ memory T cells predominate over naïve T cells in therapy-free CML patients with sustained major molecular response

Kensuke Usuki, Kazuaki Yokoyama, Tokiko Nagamura-Inoue, Ayumu Ito, Michiko Kida, Koji Izutsu, Akio Urabe, Arinobu Tojo

PMID: 19371950
DOI: 10.1016/j.leukres.2009.03.024

CD8+ memory T cells predominate over naïve T cells in therapy-free CML patients with sustained major molecular response

Kensuke Usuki et al. Leuk Res. 2009 Sep.

. 2009 Sep;33(9):e164-5.

doi: 10.1016/j.leukres.2009.03.024. Epub 2009 Apr 16.

Authors

Kensuke Usuki, Kazuaki Yokoyama, Tokiko Nagamura-Inoue, Ayumu Ito, Michiko Kida, Koji Izutsu, Akio Urabe, Arinobu Tojo

PMID: 19371950
DOI: 10.1016/j.leukres.2009.03.024

No abstract available

PubMed Disclaimer

Similar articles

A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction.
Moore H, Li NK. Moore H, et al. J Theor Biol. 2004 Apr 21;227(4):513-23. doi: 10.1016/j.jtbi.2003.11.024. J Theor Biol. 2004. PMID: 15038986
CD44high memory CD8 T cells synergize with CpG DNA to activate dendritic cell IL-12p70 production.
Wong KL, Tang LF, Lew FC, Wong HS, Chua YL, MacAry PA, Kemeny DM. Wong KL, et al. J Immunol. 2009 Jul 1;183(1):41-50. doi: 10.4049/jimmunol.0803473. Epub 2009 Jun 17. J Immunol. 2009. PMID: 19535645
Prolonged chronic phase in chronic myelogenous leukemia after homoharringtonine therapy.
Li YF, Deng ZK, Xuan HB, Zhu JB, Ding BH, Liu XN, Chen BA. Li YF, et al. Chin Med J (Engl). 2009 Jun 20;122(12):1413-7. Chin Med J (Engl). 2009. PMID: 19567163 Clinical Trial.
Pathways of memory CD8+ T-cell development.
Bannard O, Kraman M, Fearon D. Bannard O, et al. Eur J Immunol. 2009 Aug;39(8):2083-7. doi: 10.1002/eji.200939555. Eur J Immunol. 2009. PMID: 19637204 Review.
Chronic myelogenous leukemia, BCR-ABL1+.
Vardiman JW. Vardiman JW. Am J Clin Pathol. 2009 Aug;132(2):250-60. doi: 10.1309/AJCPUN89CXERVOVH. Am J Clin Pathol. 2009. PMID: 19605820 Review.

See all similar articles

Cited by

Chronic myeloid leukemia patients in prolonged remission following interferon-α monotherapy have distinct cytokine and oligoclonal lymphocyte profile.
Kreutzman A, Rohon P, Faber E, Indrak K, Juvonen V, Kairisto V, Voglová J, Sinisalo M, Flochová E, Vakkila J, Arstila P, Porkka K, Mustjoki S. Kreutzman A, et al. PLoS One. 2011;6(8):e23022. doi: 10.1371/journal.pone.0023022. Epub 2011 Aug 9. PLoS One. 2011. PMID: 21857985 Free PMC article.
Immunological off-target effects of imatinib.
Zitvogel L, Rusakiewicz S, Routy B, Ayyoub M, Kroemer G. Zitvogel L, et al. Nat Rev Clin Oncol. 2016 Jul;13(7):431-46. doi: 10.1038/nrclinonc.2016.41. Epub 2016 Mar 31. Nat Rev Clin Oncol. 2016. PMID: 27030078 Review.
Enlarged memory T-cell pool and enhanced Th1-type responses in chronic myeloid leukemia patients who have successfully discontinued IFN-α monotherapy.
Ilander M, Kreutzman A, Rohon P, Melo T, Faber E, Porkka K, Vakkila J, Mustjoki S. Ilander M, et al. PLoS One. 2014 Jan 31;9(1):e87794. doi: 10.1371/journal.pone.0087794. eCollection 2014. PLoS One. 2014. PMID: 24498197 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program